Revised International Prognostic Index

The Revised International Prognostic Index (R-IPI) is an ASSESSMENT TOOL.

The Revised International Prognostic Index is used to determine prognosis in PATIENTS with Diffuse Large B-cell Lymphoma (DLBCL).

For further information on the Revised International Prognostic Index, see the Revised International Prognostic Index calculator.

 

This supporting information is also known by these names:
ContextAlias
shortnameR-IPI

ISO 9001 CERTIFICATION EUROPE